首页 › 基金 › MONTANOVA CAPITAL, LLC › FTH
MONTANOVA CAPITAL, LLC 对 FTH 的持仓历史
FAETH THERAPEUTICS INC
MONTANOVA CAPITAL, LLC 在 Q2 2026 的 13F 申报中披露持有 FTH(FAETH THERAPEUTICS INC)2,020,103 股,市值约 US$50.5M,约占其申报组合的 0.92%,在其申报持仓中市值排名第 31 位。 MONTANOVA CAPITAL, LLC 最近 2 个申报季度中有 2 个季度披露了 FTH 持仓,最早可追溯至 Q1 2026。
最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR
MONTANOVA CAPITAL, LLC 对 FTH 的持仓演变
MONTANOVA CAPITAL, LLC 于 Q1 2026 首次披露 FTH 持仓:34,549 股(约 US$1.1M)。 该持仓在 Q2 2026 达到峰值 2,020,103 股,市值约 US$50.5M。 在 2 次申报中,MONTANOVA CAPITAL, LLC 1 次增持、0 次减持、0 次保持不变。 最近一期申报(Q2 2026)显示持股 2,020,103 股、市值约 US$50.5M,环比增持 1,985,554 股。。 持仓曾出现大幅变动:Q2 2026 增持约 5747% (随后一个季度股价上涨 19%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q1 2026 | 34.55K | $1.09M | 新进 |
| Q2 2026 | 2.02M | $50.50M | 增持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 FTH 与 13F 数据
FTH(FAETH THERAPEUTICS INC)的行业分类暂缺。我们追踪的基金中还有 46 只申报持有 FTH,申报仓位最大的包括:Avoro Capital Advisors LLC (US$36.1M), BAKER BROS. ADVISORS LP (US$32.2M), Fairmount Funds Management LLC (US$18.1M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 FTH 的基金
- Avoro Capital Advisors LLC 1.44M 股 · $36.10M · Q2 2026
- BAKER BROS. ADVISORS LP 1.29M 股 · $32.16M · Q2 2026
- Fairmount Funds Management LLC 722.02K 股 · $18.05M · Q2 2026
- Logos Global Management LP 722.02K 股 · $18.05M · Q2 2026
- Vivo Capital, LLC 722.02K 股 · $18.05M · Q2 2026
- Caligan Partners LP 629.47K 股 · $15.74M · Q2 2026
- B Group, Inc. 610.17K 股 · $15.25M · Q2 2026
- Trails Edge Capital Partners, LP 515.34K 股 · $12.88M · Q2 2026
- Octagon Capital Advisors LP 361.01K 股 · $9.03M · Q2 2026
- Cormorant Asset Management, LP 1.03M 股 · $7.66M · Q2 2026
- Boxer Capital Management, LLC 180.50K 股 · $4.51M · Q2 2026
- Patient Square Capital LP 175.05K 股 · $4.38M · Q2 2026
更多关于 MONTANOVA CAPITAL, LLC
常见问题
How long has MONTANOVA CAPITAL, LLC held FTH?
MONTANOVA CAPITAL, LLC has disclosed FTH holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
What is MONTANOVA CAPITAL, LLC's current position in FTH?
As of Q2 2026, MONTANOVA CAPITAL, LLC holds 2.02M shares of FTH (FAETH THERAPEUTICS INC), valued at $50.50M, representing 0.92% of its reported portfolio and ranking #31.
Has MONTANOVA CAPITAL, LLC been buying or selling FTH?
In the latest 13F filing (Q2 2026), MONTANOVA CAPITAL, LLC increased its position in FTH. The position peaked in Q2 2026 at 2.02M shares.
Which other funds hold FTH?
Other major institutional holders of FTH include Avoro Capital Advisors LLC, BAKER BROS. ADVISORS LP, Fairmount Funds Management LLC, among 46 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.